KSE - Delayed Quote KRW

Celltrion, Inc. (068270.KS)

158,000.00
-1,400.00
(-0.88%)
At close: 3:30:13 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,557,303,554.37
3,557,303,554.37
2,176,431,531.38
2,283,967,480.39
1,893,401,217.21
Cost of Revenue
1,875,590,283.77
1,875,590,283.77
1,124,562,480.39
1,251,270,174.70
805,806,951.54
Gross Profit
1,681,713,270.60
1,681,713,270.60
1,051,869,050.99
1,032,697,305.69
1,087,594,265.67
Operating Expense
1,189,697,736
1,189,697,736
400,387,629
385,497,437
343,415,721
Operating Income
492,015,534.60
492,015,534.60
651,481,421.99
647,199,868.69
744,178,544.67
Net Non Operating Interest Income Expense
-42,042,950.15
-42,042,950.15
9,398,448.38
6,710,770.41
-3,834,921.09
Pretax Income
576,116,811.41
576,116,811.41
671,095,784.99
626,173,376.62
738,623,430.51
Tax Provision
157,233,501.01
157,233,501.01
131,389,279.88
94,826,672.87
152,820,551.79
Net Income Common Stockholders
422,691,724.15
422,691,724.15
535,647,963.95
537,835,568.48
579,464,583.81
Basic EPS
2.05k
--
3.58k
3.56k
3.81k
Diluted EPS
2.04k
--
3.57k
3.56k
3.79k
Basic Average Shares
206,392.44
--
149,622.34
150,915.91
152,109.45
Diluted Average Shares
206,695.22
--
149,861.54
151,158.28
152,807.37
Total Operating Income as Reported
492,015,534.84
492,015,534.84
651,481,422.15
647,198,174.58
744,176,850.30
Rent Expense Supplemental
--
--
369,707
345,381
336,615
Total Expenses
3,065,288,019.77
3,065,288,019.77
1,524,950,109.39
1,636,767,611.70
1,149,222,672.54
Net Income from Continuing & Discontinued Operation
422,691,724.15
422,691,724.15
535,647,963.95
537,835,568.48
579,464,583.81
Normalized Income
433,959,935.15
433,959,935.15
529,204,230.72
537,729,094.89
589,370,155
Interest Income
33,529,333
33,529,333
19,063,734
14,218,305
4,396,155
Interest Expense
75,572,283
75,572,283
9,665,286
7,507,535
8,231,076
Net Interest Income
-42,042,950.15
-42,042,950.15
9,398,448.38
6,710,770.41
-3,834,921.09
EBIT
651,689,094.41
651,689,094.41
680,761,070.99
633,680,911.62
746,854,506.51
EBITDA
1,069,938,978.41
1,069,938,978.41
926,588,402.99
860,070,934.62
961,014,241.51
Reconciled Cost of Revenue
1,875,590,283.77
1,875,590,283.77
1,124,562,480.39
1,251,270,174.70
805,806,951.54
Reconciled Depreciation
418,249,884
418,249,884
245,827,332
226,390,023
214,159,735
Net Income from Continuing Operation Net Minority Interest
422,691,724.15
422,691,724.15
535,647,963.95
526,616,038.97
569,488,023.72
Total Unusual Items Excluding Goodwill
-15,497,886
-15,497,886
8,012,433
-13,096,345
-25,068,856
Total Unusual Items
-15,497,886
-15,497,886
8,012,433
-13,096,345
-25,068,856
Normalized EBITDA
1,085,436,864.41
1,085,436,864.41
918,575,969.99
873,167,279.62
986,083,097.51
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-4,229,675
-4,229,675
1,568,699.77
-1,983,289.08
-5,186,724.72
12/31/2021 - 7/19/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

688526.SS Wuhan Keqian Biology Co.,Ltd
16.40
-0.30%
 
207940.KS Samsung Biologics Co.,Ltd.
1,040,000.00
+0.39%
 
141080.KQ LigaChem Biosciences Inc.
98,900.00
-1.59%
 
288330.KQ Bridge Biotherapeutics, Inc.
804.00
-7.90%
 
2256.HK Abbisko Cayman Limited
7.830
+1.69%
 
028300.KQ HLB Co., Ltd.
57,800.00
+1.40%
 
9969.HK InnoCare Pharma Limited
9.650
+0.10%
 
2162.HK Keymed Biosciences Inc.
42.050
-0.36%
 
2157.HK Lepu Biopharma Co., Ltd.
4.490
-3.44%
 
2171.HK CARsgen Therapeutics Holdings Limited
16.880
+9.04%